» Articles » PMID: 20169375

Metabolic Correlations of Glucocorticoids and Polyamines in Inflammation and Apoptosis

Overview
Journal Amino Acids
Specialty Biochemistry
Date 2010 Feb 20
PMID 20169375
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Glucocorticoid hormones (GC) are essential in all aspects of human health and disease. Their anti-inflammatory and immunosuppressive properties are reasons for therapeutic application in several diseases. GC suppress immune activation and uncontrolled overproduction and release of cytokines. GC inhibit the release of pro-inflammatory cytokines and stimulate the production of anti-inflammatory cytokines. Investigation of GC's mechanism of action, suggested that polyamines (PA) may act as mediators or messengers of their effects. Beside glucocorticoids, spermine (Spm) is one of endogenous inhibitors of cytokine production. There are many similarities in the metabolic actions of GC and PA. The major mechanism of GC effects involves the regulation of gene expression. PA are essential for maintaining higher order organization of chromatin in vivo. Spermidine and Spm stabilize chromatin and nuclear enzymes, due to their ability to form complexes with negatively charged groups on DNA, RNA and proteins. Also, there is an increasing body of evidence that GC and PA change the chromatin structure especially through acetylation and deacetylation of histones. GC display potent immunomodulatory activities, including the ability to induce T and B lymphocyte apoptosis, mediated via production of reactive oxygen species (ROS) in the mitochondrial pathway. The by-products of PA catabolic pathways (hydrogen peroxide, amino aldehydes, acrolein) produce ROS, well-known cytotoxic agents involved in programmed cell death (PCD) or apoptosis. This review is an attempt in the better understanding of relation between GC and PA, naturally occurring compounds of all eukaryotic cells, anti-inflammatory and apoptotic agents in physiological and pathological conditions connected to oxidative stress or PCD.

Citing Articles

Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy-a retrospective and biomarker study.

Costa Svedman F, Liapi M, Mansson-Broberg A, Chatzidionysiou K, Egyhazi Brage S Immunooncol Technol. 2024; 22:100713.

PMID: 38952418 PMC: 11215956. DOI: 10.1016/j.iotech.2024.100713.


Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches.

Prete A, Bancos I Nat Rev Endocrinol. 2024; 20(8):460-473.

PMID: 38649778 DOI: 10.1038/s41574-024-00984-y.


Metabolism of Polyamines and Kidney Disease: A Promising Therapeutic Target.

Luo D, Lu X, Li Y, Xu Y, Zhou Y, Mao H Kidney Dis (Basel). 2023; 9(6):469-484.

PMID: 38089440 PMC: 10712987. DOI: 10.1159/000533296.


Metabolomic Analysis of Skin Biopsies from Patients with Atopic Dermatitis Reveals Hallmarks of Inflammation, Disrupted Barrier Function and Oxidative Stress.

Ilves L, Ottas A, Kaldvee B, Abram K, Soomets U, Zilmer M Acta Derm Venereol. 2021; 101(2):adv00407.

PMID: 33585945 PMC: 9366688. DOI: 10.2340/00015555-3766.


Targeted Metabolomics as a Tool in Discriminating Endocrine From Primary Hypertension.

Erlic Z, Reel P, Reel S, Amar L, Pecori A, Larsen C J Clin Endocrinol Metab. 2020; 106(4):1111-1128.

PMID: 33382876 PMC: 7993566. DOI: 10.1210/clinem/dgaa954.